Abiopharma

🔍 Griggs PC Nelson (Executive)

Company: NASDAQ, INC. (NDAQ)

Report Date: 2026-07-29

Detailed Transactions and Holdings:

• Sold 11,010 shares of Common Stock, par value $0.01 per share at $96.35 per share (Direct)
  Date: 2026-07-29 | Code: S | equity_swap_involved: false | shares_owned_after: 205,001.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: The price reported in this box is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.17 to $96.43, inclusive. The reporting person undertakes to provide to the Issuer, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F2: Represents (i) 55,950 shares or units of restricted stock, of which 20,746 are vested and (ii) 149,051 shares of Common Stock underlying PSUs, 136,209 of which are vested.